|
Sign In to gain access to subscriptions and/or personal tools.
|
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics
S L Minden
Department of Psychiatry, Brigham and Womens Hospital, Boston, MA 02115, USA, sarah_minden{at}abtassoc.com
D Frankel
Division of Health Policy and Clinical Research, Abt Associates Inc., Cambridge, MA 02138, USA
L Hadden
Division of Health Policy and Clinical Research, Abt Associates Inc., Cambridge, MA 02138, USA
J Perloff
Heller School, Brandeis University, Waltham, MA 02154, USA
K P Srinath
Division of Health Policy and Clinical Research, Abt Associates Inc., Cambridge, MA 02138, USA
D C Hoaglin
Survey Data Collection and Methods Group, Abt Associates Inc., Cambridge, MA 02138, USA
The Sonya Slifka Longitudinal Multiple Sclerosis Study follows a population-based cohort of approximately 2000 people with multiple sclerosis (MS) to study demographic and clinical characteristics, course of illness, utilization and cost of health services, provider characteristics, use of MS specialists and disease modifying agents, and neurologic, economic and psychosocial outcomes. This report describes the study methodology, presents baseline demographic and clinical data, and evaluates the representativeness of the sample. A stratified random sample of persons with established and recently-diagnosed MS selected from the National Multiple Sclerosis Society (NMSS) mailing lists was supplemented with recently-diagnosed patients recruited through systematic nationwide outreach. Baseline data were collected by computer-assisted telephone interviews derived from standardized instruments; data collection continues at six-month intervals. The cohort was comparable to population-based and clinical samples with respect to demographics, course, relapse rate, symptoms, and severity of disability. Almost two-thirds of the cohort needed help with activities of daily living, three-quarters were limited in work or other activities, and half had emotional problems that compromised quality of life. The Slifka Study cohort is broadly representative of the MS population and the database can be used to address questions not answered by natural history studies, clinical databases, or population-based surveys.
Key Words: disability epidemiology multiple sclerosis natural history patient database socioeconomics
Multiple Sclerosis, Vol. 12, No. 1,
24-38 (2006)
DOI: 10.1191/135248506ms1262oa

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. S MacAllister, C. Christodoulou, R. Troxell, M. Milazzo, P. Block, T. E Preston, H. A Bender, A. Belman, and L. B Krupp
Fatigue and quality of life in pediatric multiple sclerosis
Multiple Sclerosis,
December 1, 2009;
15(12):
1502 - 1508.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wesson, J. Cooper, L. Jehle, S. Lockhart, K. Draney, and J. Barber
The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire
Multiple Sclerosis,
October 1, 2009;
15(10):
1239 - 1249.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Julian, L Vella, D Frankel, S. Minden, J. Oksenberg, and D. Mohr
ApoE alleles, depression and positive affect in multiple sclerosis
Multiple Sclerosis,
March 1, 2009;
15(3):
311 - 315.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E Patrick, C Christodoulou, L. Krupp, and on behalf of the New York State MS Consortium
Longitudinal correlates of fatigue in multiple sclerosis
Multiple Sclerosis,
February 1, 2009;
15(2):
258 - 261.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bamer, K. Johnson, D Amtmann, and G. Kraft
Prevalence of sleep problems in individuals with multiple sclerosis
Multiple Sclerosis,
September 1, 2008;
14(8):
1127 - 1130.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M Koch, M Uyttenboogaart, A van Harten, M Heerings, and J De Keyser
Fatigue, depression and progression in multiple sclerosis
Multiple Sclerosis,
July 1, 2008;
14(6):
815 - 822.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S Minden, D Hoaglin, S Jureidini, L Hadden, D Frankel, Y Komatsuzaki, and J Outley
Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study
Multiple Sclerosis,
June 1, 2008;
14(5):
640 - 655.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Minden, D. C. Hoaglin, L. Hadden, D. Frankel, T. Robbins, and J. Perloff
Access to and utilization of neurologists by people with multiple sclerosis
Neurology,
March 25, 2008;
70(13_Part_2):
1141 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.L. Minden, D. Frankel, L. Hadden, and D.C. Hoaglin
Access to health care for people with multiple sclerosis
Multiple Sclerosis,
May 1, 2007;
13(4):
547 - 558.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Buchanan, R. Schiffer, S. Wang, A. Stuifbergen, B. Chakravorty, L. Zhu, M. Suk Kim, and W. James
Satisfaction With Mental Health Care Among People With Multiple Sclerosis in Urban and Rural Areas
Psychiatr Serv,
August 1, 2006;
57(8):
1206 - 1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Krupp
Editorial
Multiple Sclerosis,
August 1, 2006;
12(4):
367 - 368.
[PDF]
|
 |
|
|
|